| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44367c7b17bf07d2d403f117a3fe1a97 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4468 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
2005-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abe7cd132318119f7fc66995dbb43ba7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f003196c0a28d13e741867e4b692b2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca744a546af64c41f92012779baf9f93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c347272df002979d60be94b8a623205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_627f8993714507e42802d7727a5216ed |
| publicationDate |
2006-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006011159-A3 |
| titleOfInvention |
Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability |
| abstract |
The present invention relates to stable pharmaceutical composition of rabeprazole sodium in a form of enteric coated pellets, either alone or in combination with one or more prokinetic agent, preferably mosapride in a form of sustained release tablets, in a single unit dosage form, which provides enhanced bioavailability of rabeprazole. Present invention also discloses process for preparation of said pharmaceutical formulation. |
| priorityDate |
2004-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |